Publication | Closed Access

Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide–MHC class II chimera

Autoimmune DiseaseDiabetesImmune RegulationImmunologyAntigen ProcessingAutoimmunityT Cell ImmunityPeptide TherapeuticsCd4 T Cell ResponsesCellular Immune ResponseMedicineCell BiologyCell SignalingRegulatory T Cell Biology